AIIC
AJU IB Investment Company Portfolio holdings
AUM
$91.9M
This Quarter Return
+13.21%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$265M
AUM Growth
+$265M
(+0.32%)
Cap. Flow
-$2.53M
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
99.96%
Holding
11
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Kymera Therapeutics
KYMR
|
$2.53M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Atea Pharmaceuticals
AVIR
$267M
| $127M | 47.73% | 2,049,331 | – | – |
|
2
Seer Inc
SEER
$115M
| $53.3M | 20.12% | 1,066,375 | – | – |
|
3
Apellis Pharmaceuticals
APLS
$3.48B
| $47.8M | 18.05% | 1,114,962 | – | – |
|
|
4
Kymera Therapeutics
KYMR
$2.95B
| $24.8M | 9.37% | 639,059 -65,000 | -9% | -$2.53M |
|
5
Sutro Biopharma
STRO
$72.7M
| $3.98M | 1.5% | 175,000 | – | – |
|
|
MTEM
6
DELISTED
Molecular Templates, Inc.
MTEM
| $2.59M | 0.98% | 204,809 | – | – |
|
7
RAPT Therapeutics
RAPT
$188M
| $2.41M | 0.91% | 108,503 | – | – |
|
8
Clearside Biomedical
CLSD
$28.9M
| $1.96M | 0.74% | 793,555 | – | – |
|
9
Kezar Life Sciences
KZR
$28.9M
| $768K | 0.29% | 128,916 | – | – |
|
|
RNTX
10
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $740K | 0.28% | 517,558 | – | – |
|
|
BLCM
11
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $96K | 0.04% | 25,651 | – | – |
|